Treatment > Fotemustine


Glioblastoma


M. Altinbas, M. Ozkan, O. Er, H. Everest, S. H. Coskun, A. Menku, Y. Cihan, B. Kaplan
Adjuvant radiotherapy and fotemustine in treatment of anaplastic astrocytoma and glioblastoma multiforme patients
39th ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No. 459 

Fazeny-Dorner B, Veitl M, Wenzel C, Rossler K, Ungersbock K, Dieckmann K, Piribauer M, Hainfellner J, Marosi C
Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme
Br J Cancer 2003 Feb 24;88(4):496-501

Ilc K, Ferrero JM, Fischel JL, Formento P, Bryce R, Etienne MC, Milano G
Cytotoxic effects of two gamma linoleic salts (lithium gammalinolenate or meglumine gammalinolenate) alone or associated with a nitrosourea: an experimental study on human glioblastoma cell lines
Anticancer Drugs 1999 Apr;10(4):413-7 

Antonio Silvani, Elena Lamperti, Paola Gaviani, Marica Eoli, Anna Fiumani, Andrea Salmaggi, Chiara Falcone, Graziella Filippini, Andrea Botturi and Amerigo Boiardi
Salvage chemotherapy with procarbazine and fotemustine combination in the treatment of temozolomide treated recurrent glioblastoma patients
Journal of Neuro-Oncology, Epub June 19, 2007, DOI: 10.1007/s11060-007-9427-y
Abstract | Reprint |
DBLinks | BL 7:4


Gliomas


Boiardi A, Silvani A, Ciusani E, Watson A, Margison G, Berger E, Lucas C, Giroux B
Fotemustine combined with procarbazine in recurrent malignant gliomas: a phase I study with evaluation of lymphocyte 06-alkylguanine-DNA alkyltransferase activity

J Neurooncol 2001 Apr;52(2):149-56


Bourg V, Lebrun C, Chichmanian RM, Thomas P, Frenay M
Nitroso-urea-cisplatin-based chemotherapy associated with valproate: increase of haematologic toxicity
Ann Oncol 2001 Feb;12(2):217-9

Gander M, Leyvraz S, Decosterd L, Bonfanti M, Marzolini C, Shen F, Lienard D, Perey L, Colella G, Biollaz J, Lejeune F, Yarosh D, Belanich M, D'Incalci M.
Sequential administration of temozolomide and fotemustine: depletion of O6-alkyl guanine-DNA transferase in blood lymphocytes and in tumours
Ann Oncol 1999 Jul;10(7):831-8

Marzolini C, Decosterd LA, Shen F, Gander M, Leyvraz S, Bauer J, Buclin T, Biollaz J, Lejeune F.
Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous, and hepatic intra-arterial administration
Cancer Chemother Pharmacol 1998;42(6):433-40

 

HOME | Detection | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Mngt & Case Reports | Prevention | Prognosis | Psychosocial Aspects | Treatment 
About BrainLife
|
Children's Corner | E-mail Alerts | Journals | Newsletter | Patients & Caregivers | Search | Stem Cells | WHO Classification | SITEMAP